BLX vs GAB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The stock exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant fundamental concerns. Despite this, BLX trades at a discount to both Graham Number ($76.75) and intrinsic value ($63.64), supported by a low P/E of 7.90 and strong profitability margins above 72%. Recent earnings growth is exceptionally strong (YoY EPS +88.9%), but inconsistent historical earnings surprises and poor technical trend (10/100) offset optimism. The 5.27% dividend yield and low payout ratio add appeal, though insider sentiment is weak and analyst coverage is sparse.
GAB presents a classic deep-value opportunity, characterized by a strong Piotroski F-Score of 7/9 and a significant discount to its Graham Number ($11.1) and Intrinsic Value ($28.91). The company maintains an exceptionally low P/E ratio of 5.72 compared to the sector average of 38.56, paired with a robust 10.7% dividend yield. While technical trends are currently bearish (0/100) and insider sentiment is weak, the fundamental health—marked by minimal debt and double-digit earnings growth—provides a substantial margin of safety.
Compare Another Pair
Related Comparisons
BLX vs GAB: Head-to-Head Comparison
This page compares Banco Latinoamericano de Comercio Exterior, S. A. (BLX) and The Gabelli Equity Trust Inc. (GAB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.